Atlas Trials

Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Clinical trial NCT05955326 · RECRUITING

Trial details

NCT number
NCT05955326
Sponsor
Pharmazz, Inc.
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Cerebral Ischemia
Start date
2024-01-08
Primary completion
2026-02-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.